The Translation of Nanomedicines in the Contexts of Spinal Cord Injury and Repair.

The advance of nanotechnologies for the treatment of refractory spinal cord pathologies requires an in-depth understanding of neurobiological and topographical principles and a consideration of additional complexities involving the research's translational and regulatory landscapes.